7 / 31
Page 39
Notes:
conference
series
.com
Volume 6, Issue 5 (Suppl)
OMICS J Radiol, an open access journal
ISSN: 2167-7964
Radiology and Oncology 2017
October 19-20, 2017
World Congress on
October 19-20, 2017 | New York, USA
Radiology and Oncology
Role of Computed Tomography in the Evaluation of Renal Masses
Akshay Kapila
Rajiv Gandhi Cancer Hospital, India
Aims and Objective:
To evaluate Renal Masses on CT scan and to compare the enhancement of renal neoplasm and renal cortex
during corticomedullary and nephrographic phase.
Materials and Methods:
The patients were evaluated through history, physical examination, Ultrasonography and computed
tomography was carried out using TOSHIBA ACTIVION 16SLICE CT SCANNER.
Result:
The study included 32 cases of renal masses between age group of 22-82 years. Thirty three lesions were detected in 32 patients.
Of these, Renal cell Carcinoma (22 cases), Transitional cell carcinoma (3 cases), Angiomyolipoma (1 case), renal oncocytoma (1 case),
Renal metastasis (1 case), Renal abscess (1 case) and three lesions were cystic lesions.
Conclusion:
1. Renal neoplasm showed greater enhancement in the nephrographic phase compared with that in corticomedullary phase.
2. Renal cortex also showed greater enhancement in the nephrographic phase compared with the corticomedullary phase.
Biography
Dr. Akshay kapila has completed his MBBS at the age of 23 years from Bharti Vidyapeeth University, Pune and postgraduate studies from Maharashtra University of Health
Sciences, Nashik. He is currently pursuing Fellowship in Whole Body Imaging from Rajiv Gandhi Cancer Hospital, New-Delhi. He has published a paper in International
journal of Health Science.
kapilaakshay@gmail.comAkshay Kapila, OMICS J Radiol 2017, 6:5 (Suppl)
DOI: 10.4172/2167-7964-C1-015
Enhancement of Renal Neoplasms
Variable
Hounc e f i e l d
Units
Unenhanced attenuation
23+/- 7
Corticomedullary phase attenuation
49+/- 22
Nephrographic phase attenuation
68+/- 26
Corticomedullary phase enhancement
23+/- 14
Nephrographic phase enhancement
47+/-19
Enhancement of Renal Cortex
Variable
Hounc e f i e l d
Units
Unenhanced attenuation
32+/- 3
Corticomedullary phase attenuation
137+/- 30
Nephrographic phase attenuation
163+/- 36
Corticomedullary phase enhancement
105+/- 29
Nephrographic phase enhancement
131+/- 40